NetScientific Shares Rise on Head-and-Neck Cancer Therapy Result

By Michael Susin

NetScientific shares rose on Wednesday after the group said that its portfolio company achieved an efficacy threshold for the head-and-neck cancer treatment PDS0101.

Shares at 1524 GMT were up 5.5 pence, or 8.3%, at 71.5 pence

The…